NHS weight loss injections: eligibility, costs, and safe access guide (2026)
Weight loss injections have become one of the most discussed topics in UK healthcare over the past few years. With medications like semaglutide gaining widespread attention, many people in England, Scotland, Wales, and Northern Ireland are asking whether they qualify for treatment through the NHS, what it might cost privately, and how to access it safely and responsibly.
Prescription-based weight loss injections work by mimicking hormones that regulate appetite and blood sugar levels. When used as part of a supervised treatment plan, they can support significant and sustained weight reduction. However, access is not straightforward for everyone, and understanding the system is key before pursuing any route — NHS or otherwise.
What Are Weight Loss Injections?
Medications such as semaglutide (marketed as Wegovy or Ozempic) and liraglutide (Saxenda) are injectable treatments approved for weight management in the UK. These belong to a class called GLP-1 receptor agonists. They slow digestion, reduce hunger signals, and can help people with obesity manage their weight more effectively when combined with diet and lifestyle changes. Dosage is typically increased gradually under medical supervision to reduce side effects and improve tolerance.
NHS Eligibility and Referral Criteria
NHS access to weight loss injections is available but subject to strict eligibility criteria. In England, Wegovy (semaglutide) received NICE approval for use within specialist weight management services. To qualify, patients generally need a BMI of 35 or above alongside at least one weight-related health condition such as type 2 diabetes, high blood pressure, or sleep apnoea. In some cases, a BMI of 30 or above may be considered for certain high-risk groups. Referral typically comes through a GP, who can direct patients to specialist obesity clinics or structured NHS weight management programmes. It is worth noting that NHS availability may vary by region due to local commissioning decisions.
Prescriptions Through NHS vs Private Clinics
For those who do not meet NHS thresholds or face long waiting lists, private clinics offer an alternative route to obtaining a prescription. Private healthcare providers can prescribe weight loss injections following an online or in-person consultation, medical history review, and BMI assessment. While this increases accessibility, it also raises the importance of choosing regulated providers registered with the Care Quality Commission (CQC) or working with GMC-registered prescribers. Self-administering medication without proper medical oversight carries genuine health risks and should always be avoided.
BMI, Obesity Classification, and Treatment Decisions
BMI remains the primary clinical measure used to assess obesity and determine treatment suitability. A BMI between 25 and 29.9 is classified as overweight, 30 to 34.9 as obese (Class I), 35 to 39.9 as obese (Class II), and 40 or above as severely obese (Class III). Weight loss injection treatment is generally targeted at Class II obesity and above within NHS frameworks, though private clinics may apply slightly different thresholds. Healthcare professionals also consider broader factors such as cardiovascular risk, existing medication, and mental health when assessing suitability.
Safe and Supervised Use of Weight Loss Medication
Safety is paramount when using any prescription medication for weight loss. Injections should always be administered as directed, with dosage adjustments made by a qualified healthcare provider. Common side effects include nausea, vomiting, and digestive discomfort, particularly during the early stages of treatment. Regular check-ins with a clinic or GP are recommended to monitor progress and flag any adverse reactions. Patients are advised to avoid purchasing these medications from unregulated online sources, as counterfeit products have been identified in the UK market.
| Medication | Provider Type | Estimated Monthly Cost |
|---|---|---|
| Wegovy (semaglutide) | NHS Specialist Service | Free (if eligible) |
| Wegovy (semaglutide) | Private Clinic (e.g. Boots, Superdrug Health) | £150–£300 per month |
| Saxenda (liraglutide) | Private Clinic | £180–£280 per month |
| Ozempic (semaglutide, off-label) | Private GP/Clinic | £100–£250 per month |
| Mounjaro (tirzepatide) | Private Clinic | £150–£350 per month |
Prices, rates, or cost estimates mentioned in this article are based on the latest available information but may change over time. Independent research is advised before making financial decisions.
How to Access Treatment Responsibly in the UK
The most straightforward starting point for anyone considering weight loss injections in the UK is a conversation with their GP. A GP can assess eligibility, provide a referral to an NHS obesity clinic, or advise on reputable private options. For those exploring private treatment, clinics registered with the CQC and staffed by GMC-registered professionals offer a safer route than unverified online pharmacies. Always ensure a full medical consultation takes place before any prescription is issued, and be cautious of services that skip clinical assessment steps.
Weight loss injections can be an effective part of a broader health strategy for those who meet clinical criteria, but they are not a standalone solution. Long-term success depends on combining medication with sustainable lifestyle changes, ongoing medical support, and realistic expectations about outcomes and timelines.
